4//SEC Filing
Atlas Venture Associates VIII, L.P. 4
Accession 0000899243-18-019323
CIK 0001693415other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 6:43 PM ET
Size
16.2 KB
Accession
0000899243-18-019323
Insider Transaction Report
Form 4
Atlas Venture Fund VIII, L.P.
10% Owner
Transactions
- Conversion
Series C Preferred Stock
2018-07-02−2,525,253→ 0 total→ Common Stock (454,550 underlying) - Conversion
Series A Preferred Stock
2018-07-02−12,925,244→ 0 total→ Common Stock (2,326,567 underlying) - Conversion
Series B Preferred Stock
2018-07-02−5,838,230→ 0 total→ Common Stock (1,050,891 underlying) - Conversion
Common Stock
2018-07-02+3,832,010→ 3,922,010 total
Footnotes (2)
- [F1]The Series A, Series B and Series C Preferred Stock converted into Common Stock on a 5.5555-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A, Series B and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
- [F2]These shares are held directly by Atlas Venture Fund VIII, L.P. ("Atlas Venture Fund VIII"). The general partner of Atlas Venture Fund VIII is Atlas Venture Associate VIII, L.P. ("AVA VIII LP"). Atlas Venture Associates VIII, Inc. ("AVA VIII INC") is the general partner of AVA VIII LP. Each of AVA VIII LP and AVA VIII INC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund VIII, except to the extent of its pecuniary interest therein, if any. This report shall not be deemed to be an admission that the reporting persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose
Documents
Issuer
Translate Bio, Inc.
CIK 0001693415
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001451625
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 6:43 PM ET
- Size
- 16.2 KB